A team at Harvard University and Massachusetts-based Advanced Cell Technology Inc. have taken another step forward in the development of technology for versatile, grow-in-a-dish transplant tissue, announcing that they have found a safe way to turn skin cells into stem cells.
If you’ve ever met with a financial planner or investment advisor, then you know that one of the first rules of
investing is diversification, an important risk management technique that ensures there are a variety of assets within a portfolio. As biopharmaceutical
organizations, it is important that we recognize the dire consequences that may result if we ignore this proven strategy.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.